Loading...
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
Vesicular stomatitis virus (VSV), like many other Rhabdoviruses, have become the focus of intense research over the past couple of decades based on their suitability as vaccine vectors, transient gene delivery systems, and as oncolytic viruses for cancer therapy. VSV as a vaccine vector platform has...
Saved in:
| Published in: | AIDS Res Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5594459/ https://ncbi.nlm.nih.gov/pubmed/28893277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-017-0179-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|